Moorfields Eye Hospital delivered a surplus of £5.7m in the 2017/18 financial year, which has increased from £2.6m in 2016/17.
Highlights and developments from its annual review were shared at the London hospital’s annual general meeting at London Symphony Orchestra St Luke’s on 19 July.
Chief executive of Moorfields, David Probert, said NHS income was relatively stable while its private income had increased year-on-year.
He confirmed that the £5.7m surplus would be put towards NHS services to support research and reinvested back into private practice.
“We all know that the NHS is in a difficult and turbulent time…One of the ways that we support ourselves is through diversifying,” he said.
In the report, the hospital’s accident and emergency services were highlighted by the Care Quality Commission as consistently delivering high quality care and patient experience, achieving the 95% four-hour target throughout the year.
Moorfields shared that 96% of patients have visual stability after injections for macular degeneration, compared to the national standard of 80%. Additionally, 98% of patients have a successful outcome 12 months after having surgery for keratoconus, compared to the national standard of 90%.
Image credit: Laurence Derbyshire